MBX Biosciences Inc

MBX Biosciences insider sale: CMO Azoulay Salomon’s 231‑share tax‑cover sale shows routine liquidity use, not confidence loss, amid strong pipeline and earnings momentum.

CEO Kent’s $16 share buy at MBX Biosciences shows strong conviction amid 52‑week swings, signaling potential upside for cautious investors.

MBX Biosciences insiders, including CFO Bartram, buy‑and‑hold 15k RSUs and 70k options, signaling confidence amid volatile biotech stock.